Skip to Content

Emo Capital Corp NUVI

Morningstar Rating
$0.01 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NUVI is trading at a 237% premium.
Price
$0.01
Fair Value
$5.44
Uncertainty
Extreme
1-Star Price
$4.00
5-Star Price
$4.87
Economic Moat
Dfw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NUVI is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.010.01
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.01
Market Cap
$237,850.00
Volume/Avg
2,222 / 3,704

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Emo Capital Corp is a United States based company and has made a decision to expand company's business to cannabis nursery sector. It has planned to build a cannabis nursery facility in California City to provide cannabis seedlings to meet the growing demand of cannabis cultivators in California.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
NUVI
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NUVI
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
NUVI

Profitability

Metric
NUVI
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
DggvrhdwdrGxnvfwc$80.3 Bil
Zoetis Inc Class A
ZTS
RdtnksvvkKbzm$77.8 Bil
Haleon PLC ADR
HLN
QstzysdkvBbjy$37.8 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
TptjvmbdPfqq$12.1 Bil
Viatris Inc
VTRS
ZmqxgtjnPwbx$12.1 Bil
Catalent Inc
CTLT
PptrwknkLzzxdq$10.0 Bil
Perrigo Co PLC
PRGO
SbjfhgvQtb$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
SnlghmrZlkjnlf$3.2 Bil
Curaleaf Holdings Inc
CURLF
RshqdcylFcpn$3.0 Bil
Green Thumb Industries Inc
GTBIF
QgncrqsbfYnvyl$2.7 Bil

Sponsor Center